Sicart Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $552K | Hold |
2,260
| – | – | 0.14% | 53 |
|
|
2025
Q4 | $468K | Hold |
2,260
| – | – | 0.12% | 53 |
|
|
2025
Q3 | $419K | Hold |
2,260
| – | – | 0.11% | 53 |
|
|
2025
Q2 | $345K | Sell |
2,260
-500
| -18% | -$76.9K | 0.12% | 55 |
|
|
2025
Q1 | $458K | Hold |
2,760
| – | – | 0.16% | 50 |
|
|
2024
Q4 | $399K | Hold |
2,760
| – | – | 0.14% | 52 |
|
|
2024
Q3 | $447K | Hold |
2,760
| – | – | 0.16% | 53 |
|
|
2024
Q2 | $403K | Sell |
2,760
-270
| -9% | -$40.2K | 0.15% | 55 |
|
|
2024
Q1 | $479K | Hold |
3,030
| – | – | 0.18% | 54 |
|
|
2023
Q4 | $475K | Hold |
3,030
| – | – | 0.18% | 51 |
|
|
2023
Q3 | $472K | Hold |
3,030
| – | – | 0.19% | 49 |
|
|
2023
Q2 | $502K | Sell |
3,030
-157
| -5% | -$25.3K | 0.19% | 50 |
|
|
2023
Q1 | $494K | Sell |
3,187
-3,000
| -48% | -$484K | 0.19% | 49 |
|
|
2022
Q4 | $1.09M | Hold |
6,187
| – | – | 0.39% | 45 |
|
|
2022
Q3 | $1.01M | Sell |
6,187
-2,500
| -29% | -$423K | 0.36% | 45 |
|
|
2022
Q2 | $1.54M | Sell |
8,687
-165
| -2% | -$29.4K | 0.48% | 43 |
|
|
2022
Q1 | $1.57M | Buy |
8,852
+150
| +2% | +$25.5K | 0.41% | 45 |
|
|
2021
Q4 | $1.5M | Hold |
8,702
| – | – | 0.39% | 42 |
|
|
2021
Q3 | $1.41M | Buy |
8,702
+157
| +2% | +$26.8K | 0.38% | 42 |
|
|
2021
Q2 | $1.41M | Hold |
8,545
| – | – | 0.34% | 43 |
|
|
2021
Q1 | $1.4M | Sell |
8,545
-300
| -3% | -$48.5K | 0.37% | 40 |
|
|
2020
Q4 | $1.39M | Sell |
8,845
-4,790
| -35% | -$707K | 0.34% | 46 |
|
|
2020
Q3 | $2.03M | Sell |
13,635
-100
| -0.7% | -$14.8K | 0.61% | 39 |
|
|
2020
Q2 | $1.93M | Sell |
13,735
-26
| -0.2% | -$3.79K | 0.62% | 40 |
|
|
2020
Q1 | $1.8M | Hold |
13,761
| – | – | 0.69% | 39 |
|
|
2019
Q4 | $2.01M | Hold |
13,761
| – | – | 0.67% | 32 |
|
|
2019
Q3 | $1.78M | Buy |
13,761
+815
| +6% | +$107K | 0.58% | 35 |
|
|
2019
Q2 | $1.8M | Buy |
12,946
+400
| +3% | +$55.4K | 0.73% | 34 |
|
|
2019
Q1 | $1.75M | Hold |
12,546
| – | – | 0.74% | 31 |
|
|
2018
Q4 | $1.62M | Hold |
12,546
| – | – | 0.78% | 30 |
|
|
2018
Q3 | $1.73M | Hold |
12,546
| – | – | 0.83% | 30 |
|
|
2018
Q2 | $1.52M | Hold |
12,546
| – | – | 0.8% | 32 |
|
|
2018
Q1 | $1.61M | Hold |
12,546
| – | – | 0.96% | 27 |
|
|
2017
Q4 | $1.75M | Buy |
12,546
+7,000
| +126% | +$975K | 0.93% | 33 |
|
|
2017
Q3 | $721K | Hold |
5,546
| – | – | 0.52% | 43 |
|
|
2017
Q2 | $734K | Hold |
5,546
| – | – | 0.53% | 42 |
|
|
2017
Q1 | $691K | Sell |
5,546
-500
| -8% | -$59.7K | 0.5% | 50 |
|
|
2016
Q4 | $697K | Buy |
+6,046
| New | +$698K | 0.48% | 61 |
|
Other funds holding JNJ
VCM
VPM
Sicart Associates's JNJ Position: Q1 2026 in Review
Sicart Associates held its Johnson & Johnson (JNJ) position steady in Q1 2026 at 2,260 shares worth $552K. The position accounts for 0.14% of the portfolio, ranked #53.
Sicart Associates first reported a position in JNJ in Q4 2016 and has held it in 38 quarters since. The position peaked at $2.03M in Q3 2020. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Sicart Associates held 2,260 shares of Johnson & Johnson worth $552K as of Q1 2026.
- Sicart Associates left its Johnson & Johnson share count unchanged in Q1 2026.
- Johnson & Johnson made up 0.14% of Sicart Associates's portfolio in Q1 2026, its #53 holding.
- Sicart Associates first reported a position in Johnson & Johnson in Q4 2016 and has held it in 38 quarters since.
- Sicart Associates's Johnson & Johnson position peaked at $2.03M in Q3 2020.
- 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Sicart Associates's 13F filing for Q1 2026, filed 21 Apr 2026.